Medical Morphine Market Research Report – Forecast to 2027

Medical Morphine Market Information: By Route of Administration (Oral, Injectables) Application (Arthritis, Cancer, Kidney Stones,) Distribution Channel (Hospital Pharmacy, Online Pharmacy), and End-User (Hospitals & Clinics )– Global Forecast Till 2027

ID: MRFR/Pharma/4626-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The medical morphine market is expected to register a CAGR of 7.5% during the forecast period of 2018–2023. The global medical morphine market is majorly driven by the increasing prescription of painkillers for different illnesses such as arthritis, cardiovascular disorders and cancer, growing older population leading to the rising patient population, and growing penetration by market players. For instance, according to the American Heart Association, in 2014, one in every three deaths in the U.S. was due to cardiovascular disorders. Similarly, cardiovascular disorders had claimed over 801,000 lives in 2014 in the U.S. Additionally, the increasing use of painkillers to relieve pain in postoperative surgeries is likely to drive the growth of the morphine market globally. However, addiction to morphine leading to drug abuse is likely to hamper the growth of the market. Likely the limited regulatory scenario is also expected to turn as a challenge for the market.


Market Segmentation                                                                                                                          


The global medical morphine market has been segmented by route of administration, application, distribution channel, end-user, and region. Further, the market by route of administration is segmented into oral and injectables. Based on application, the market is segmented into arthritis, cancer, myocardial infarction, kidney stones, diarrhea, and others. With reference to distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others. On account of end-user, the market is segmented into hospitals and clinics, home care, and ambulatory surgical centers. Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.


Regional Market Summary


Global Medical Morphine Market Share (%), by Region, 2017


  Medical Morphine Market Share


Source: World Health Organization, Centers for Disease Control and Prevention, expert interview, annual report, white paper, company presentation and market research future analysis


Americas held the largest share of the medical morphine market in 2017. The increasing prevalence of arthritis and other inflammatory disorders and rising more elderly population are likely to enhance the growth of the medical morphine market in the American region. Additionally, factors such as prescription of painkillers, increasing government initiatives, and funding for research and development in advanced medical treatment options are likely to enhance the growth of the medical morphine market in the American region. For instance, according to the American Heart Association, in 2014, around 31% of the deaths in the U.S. were due to cardiovascular disorders. Additionally, according to CDC, around 54.4 million U.S. adults were affected by arthritis in 2015. This growth rate of cardiovascular disorders and arthritis is expected to have a direct effect on medical morphine as it helps to relieve joint pain and postsurgical pain.


Europe is the second largest market and is expected to hold a healthy share in the global medical morphine market during the forecast period, 2018–2023. The European market is expected to grow at a sturdy growth rate during the forecast period owing to the lucrative growth of the healthcare sector coupled with the increasing prevalence of arthritis. Furthermore, increasing inflammatory disorders, along with the rising elder population leading to increasing patient population are also supporting the growth of the medical morphine market.


Asia Pacific is expected to be the fastest growing market during the forecast period of 2018–2023. Factors such as the increasing prevalence of chronic diseases such as cardiovascular disorders are the major drivers for the market growth. China is expected to be the fastest growing country due to increasing population, eventually rising patient population and the availability of new treatment methods. Moreover, rising healthcare expenditure in the region is driving the growth of the medical morphine market in the Asia Pacific region.


The Middle East and Africa is expected to show the least growth in the market due to some major factors such as lack of awareness and limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market owing to the development of the healthcare industry and rising availability of specialty care centers.


Research Methodology:


 Medical Morphine Market Method


Source: World Health Organization, Centers for Disease Control and Prevention, American Heart Association, National Institute of Health, American College of Cardiology, European Heart Network, expert interview, annual report, white paper, company presentation and market research future analysis


Market Segmentation & Key players


Medical Morphine Market, by Route of Administration



  • Oral

  • Injectables

  • Others


Medical Morphine Market, by Application



  • Arthritis

  • Cancer

  • Myocardial infarction

  • Kidney stones

  • Diarrhea

  • Others


Medical Morphine Market, by Distribution Channel



  • Hospital Pharmacy

  • Retail Pharmacy

  • Online Pharmacy

  • Others


Medical Morphine Market, by End-User



  • Hospitals & Clinics

  • Ambulatory Surgical Centers

  • Homecare

  • Others


Medical Morphine Market, by Region


North America



  • U.S.

  • Canada


South America


Europe



  • Western Europe

  • Germany

  • France

  • K.

  • Italy

  • Spain

  • Rest of Western Europe

  • Eastern Europe


Asia Pacific



  • Japan

  • China

  • India

  • Australia

  • Republic of Korea

  • Rest of Asia Pacific


Middle East and Africa



  • United Arab Emirates

  • Saudi Arabia

  • Oman

  • Kuwait

  • Qatar

  • Rest of the Middle East & Africa


Market Players



  • Mallinckrodt Pharmaceuticals

  • Alcaliber S.A

  • Purdue Pharma L.P.

  • Pfizer Inc.

  • Johnson Matthey Fine Chemicals

  • Sun Pharmaceutical Industries Ltd.

  • Verve Health Care Ltd.

  • Taj Pharmaceuticals Limited

  • NORTHEAST PHARM

  • MANUS AKTTEVA BIOPHARMA LLP


Intended Audience



  • Pharmaceutical Manufacturers and Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors



Frequently Asked Questions (FAQ) :


The global medical morphine market can expand at 7.5% CAGR from 2020 to 2027.

The large geriatric populace and prevalence of cardiovascular diseases and others are major drivers of the global medical morphine market.

The global medical morphine market growth is hampered by cases of painkiller medication.

The Americas can dominate the global medical morphine market till 2027 due to prevalence of arthritis and cardiovascular disorders.

MANUS AKTTEVA BIOPHARMA LLP, Purdue Pharma L.P., Johnson Matthey Fine Chemicals, NORTHEAST PHARM, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Verve Health Care Ltd., Alcaliber S.A, Mallinckrodt Pharmaceuticals, and Taj Pharmaceuticals Limited are major players of the global medical morphine market.

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Medical Morphine Market, by Route of Administration

6.1 Introduction

6.2 Oral

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

6.3 Injectables

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

6.4 Others

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

7. Global Medical Morphine Market, by Application

7.1 Introduction

7.2 Arthritis

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

7.3 Cancer

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

7.4 Myocardial infarction

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

7.5 Kidney stones

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

7.6 Diarrhea

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

7.7 Others

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

8. Global Medical Morphine Market, by Distribution Channel

8.1 Introduction

8.2 Hospital Pharmacy

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

8.3 Retail Pharmacy

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

8.4 Online Pharmacy

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

8.5 Others

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027


9. Global Medical Morphine Market, by End-User

9.1 Introduction

9.2 Hospitals & Clinics

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

9.3 Ambulatory Surgical Centers

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

9.4 Homecare

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

9.5 Others

• Market Estimates & Forecast, 2020–2027

• Market Estimates & Forecast, by Region/Country, 2020–2027

10 Global Medical Morphine Market, by Region

10.1 Introduction

10.2 Americas

• Market Estimates & Forecast, by Region, 2020–2027

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.2.1 North America

• Market Estimates & Forecast, by Country, 2020–2027

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.2.1.1 U.S.

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.2.1.2 Canada

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.2.2 South America

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.3 Europe

• Market Estimates & Forecast, by Region, 2020–2027

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.3.1 Western Europe

• Market Estimates & Forecast, by Country, 2020–2027

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.3.1.1 Germany

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.3.1.2 France

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.3.1.3 U.K.

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.3.1.4 Italy

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.3.1.5 Spain

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.3.1.6 Rest of Western Europe

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.3.2 Eastern Europe

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.4 Asia Pacific

• Market Estimates & Forecast, by Country, 2020–2027

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.4.1 Japan

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.4.2 China

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.4.3 India

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.4.4 Australia

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.4.5 Republic of Korea

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.4.6 Rest of Asia Pacific

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.5 The Middle East & Africa

• Market Estimates & Forecast, by Region, 2020–2027

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.5.1 United Arab Emirates

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.5.2 Saudi Arabia

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.5.3 Oman

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.5.4 Kuwait

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.5.5 Qatar

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

10.5.6 Rest of the Middle East & Africa

• Market Estimates & Forecast, by Route of Administration, 2020–2027

• Market Estimates & Forecast, by Application, 2020–2027

• Market Estimates & Forecast, by Distribution Channel, 2020–2027

• Market Estimates & Forecast, by End-User, 2020–2027

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Mallinckrodt Pharmaceuticals

12.1.1 Company Overview

12.1.2 Application Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Alcaliber S.A.

12.2.1 Company Overview

12.2.2 Application Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Purdue Pharma L.P.

12.3.1 Company Overview

12.3.2 Application Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Pfizer Inc.

12.4.1 Company Overview

12.4.2 Application/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Johnson Matthey Fine Chemicals

12.5.1 Company Overview

12.5.2 Application Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Sun Pharmaceutical Industries Ltd.

12.6.1 Company Overview

12.6.2 Application Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Verve Health Care Ltd.

12.7.1 Overview

12.7.2 Application Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Taj Pharmaceuticals Limited

12.8.1 Overview

12.8.2 Application Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 NORTHEAST PHARM

12.9.1 Overview

12.9.2 Application Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 MANUS AKTTEVA BIOPHARMA LLP

12.10.1 Overview

12.10.2 Application Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

13 Appendix

LIST OF TABLES

Table 1 Medical Morphine Industry Synopsis, 2020–2027

Table 2 Global Medical Morphine Market Estimates and Forecast, 2020–2027, (USD Million)

Table 3 Global Medical Morphine Market, by Region, 2020–2027, (USD Million)

Table 5 Global Medical Morphine Market, by Route of Administration, 2020–2027, (USD Million)

Table 5 Global Medical Morphine Market, by Application, 2020–2027, (USD Million)

Table 6 Global Medical Morphine Market, by Distribution Channel, 2020–2027, (USD Million)

Table 7 Global Medical Morphine Market, by End-User, 2020–2027, (USD Million)

Table 8 North America Medical Morphine Market, by Route of Administration, 2020–2027, (USD Million)

Table 9 North America Medical Morphine Market, by Distribution Channel, 2020–2027, (USD Million)

Table 9 North America Medical Morphine Market, by Application, 2020–2027, (USD Million)

Table 10 North America Medical Morphine Market, by End-User, 2020–2027, (USD Million)

Table 11 U.S. Medical Morphine Market, by Route of Administration, 2020–2027, (USD Million)

Table 12 U.S. Medical Morphine Market, by Distribution Channel, 2020–2027, (USD Million)

Table 12 U.S. Medical Morphine Market, by Application, 2020–2027, (USD Million)

Table 13 U.S. Medical Morphine Market, by End-User, 2020–2027, (USD Million)

Table 14 Canada Medical Morphine Market, by Route of Administration, 2020–2027, (USD Million)

Table 14 Canada Medical Morphine Market, by Application, 2020–2027, (USD Million)

Table 15 Canada Medical Morphine Market, by Distribution Channel, 2020–2027, (USD Million)

Table 16 Canada Medical Morphine Market, by End-User, 2020–2027, (USD Million)

Table 17 South America Medical Morphine Market, by Route of Administration, 2020–2027, (USD Million)

Table 18 South America Medical Morphine Market, by Distribution Channel, 2020–2027, (USD Million)

Table 19 South America Medical Morphine Market, by End-User, 2020–2027, (USD Million)

Table 20 Europe Medical Morphine Market, by Route of Administration, 2020–2027, (USD Million)

Table 21 Europe Medical Morphine Market, by Distribution Channel, 2020–2027, (USD Million)

Table 22 Europe Medical Morphine Market, by End-User, 2020–2027, (USD Million)

Table 23 Western Europe Medical Morphine Market, by Route of Administration, 2020–2027, (USD Million)

Table 24 Western Europe Medical Morphine Market, by Distribution Channel, 2020–2027, (USD Million)

Table 25 Western Europe Medical Morphine Market, by End-User, 2020–2027, (USD Million)

Table 26 Eastern Europe Medical Morphine Market, by Route of Administration, 2020–2027, (USD Million)

Table 27 Eastern Europe Medical Morphine Market, by Distribution Channel, 2020–2027, (USD Million)

Table 28 Eastern Europe Medical Morphine Market, by End-User, 2020–2027, (USD Million)

Table 29 Asia Pacific Medical Morphine Market, by Route of Administration, 2020–2027, (USD Million)

Table 30 Asia Pacific Medical Morphine Market, by Distribution Channel, 2020–2027, (USD Million)

Table 31 Asia Pacific Medical Morphine Market, by End-User, 2020–2027, (USD Million)

Table 32 Middle East & Africa Medical Morphine Market, by Route of Administration, 2020–2027, (USD Million)

Table 33 Middle East & Africa Medical Morphine Market, by diagnoses, 2020–2027, (USD Million)

Table 34 Middle East & Africa Medical Morphine Market, by End-User, 2020–2027, (USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Medical Morphine Market

Figure 3 Segmentation Market Dynamics for Medical Morphine Market

Figure 4 Global Medical Morphine Market Share, by Route of Administration 2020

Figure 5 Global Medical Morphine Market Share, by Application 2020

Figure 6 Global Medical Morphine Market Share, by End-User, 2020

Figure 7 Global Medical Morphine Market Share, by Region, 2020

Figure 8 North America Medical Morphine Market Share, by Country, 2020

Figure 9 Europe Medical Morphine Market Share, by Country, 2020

Figure 10 Asia Pacific Medical Morphine Market Share, by Country, 2020

Figure 11 Middle East & Africa Medical Morphine Market Share, by Country, 2020

Figure 12 Global Medical Morphine Market: Company Share Analysis, 2020 (%)

Figure 13 Mallinckrodt Pharmaceuticals: Key Financials

Figure 14 Mallinckrodt Pharmaceuticals: Segmental Revenue

Figure 16 Mallinckrodt Pharmaceuticals: Geographical Revenue

Figure 17 Alcaliber S.A. Key Financials

Figure 18 Alcaliber S.A: Segmental Revenue

Figure 19 Alcaliber S.A: Geographical Revenue

Figure 20 Pfizer Inc.: Key Financials

Figure 21 Pfizer Inc: Segmental Revenue

Figure 22 Pfizer Inc: Geographical Revenue

Figure 23 Sun Pharmaceutical: Key Financials

Figure 24 Sun Pharmaceutical: Segmental Revenue

Figure 25 Sun Pharmaceutical: Geographical Revenue

Figure 26 Verve Health Care Ltd.: Key Financials

Figure 27 Verve Health Care Ltd: Segmental Revenue

Figure 28 Verve Health Care Ltd. Geographical Revenue